NRX Pharmaceuticals, Inc. Earnings Per Share, Basic and Diluted
NRX Pharmaceuticals, Inc. (NRXP) reported Earnings Per Share, Basic and Diluted of -$0.33 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-21.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-05-21
- NRX Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.33, a 430.00% decline year-over-year.
- NRX Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.05.
- NRX Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.06.
- NRX Pharmaceuticals, Inc. earnings per share, basic and diluted for the quarter ending 2020-03-31 was $0.10.
- NRX Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2019 was -$0.11.
- NRX Pharmaceuticals, Inc. earnings per share, basic and diluted for fiscal 2018 was -$0.29.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$0.33 10-Q · filed 2021-05-21 | |||
| 2020-09-30 | -$0.05 10-Q · filed 2020-11-16 | -$1.87 derived: net income ÷ weighted average shares · filed 2022-08-12 | $0.00 10-Q · filed 2020-11-16 | -$1.75 derived: net income ÷ weighted average shares · filed 2022-08-12 |
| 2020-06-30 | -$0.06 10-Q · filed 2020-08-14 | $0.04 10-Q · filed 2020-08-14 | $0.11 derived: net income ÷ weighted average shares · filed 2022-08-12 | $0.08 derived: net income ÷ weighted average shares · filed 2022-08-12 |
| 2020-03-31 | $0.10 10-Q · filed 2021-05-21 | $0.08 derived: net income ÷ weighted average shares · filed 2021-05-21 | $0.04 derived: net income ÷ weighted average shares · filed 2021-05-21 | $0.01 derived: net income ÷ weighted average shares · filed 2021-05-21 |
| 2019-12-31 | -$0.02 derived: net income ÷ weighted average shares · filed 2020-03-30 | -$0.06 derived: net income ÷ weighted average shares · filed 2020-11-16 | -$0.09 derived: net income ÷ weighted average shares · filed 2020-11-16 | -$0.11 10-K · filed 2020-03-30 |
| 2019-09-30 | -$0.04 10-Q · filed 2020-11-16 | -$0.07 derived: net income ÷ weighted average shares · filed 2020-11-16 | -$0.09 10-Q · filed 2020-11-16 | -$0.19 derived: net income ÷ weighted average shares · filed 2020-11-16 |
| 2019-06-30 | -$0.03 10-Q · filed 2020-08-14 | -$0.06 10-Q · filed 2020-08-14 | -$0.15 derived: net income ÷ weighted average shares · filed 2020-08-14 | -$0.21 derived: net income ÷ weighted average shares · filed 2020-08-14 |
| 2019-03-31 | -$0.03 10-Q · filed 2020-05-15 | -$0.12 derived: net income ÷ weighted average shares · filed 2020-05-15 | -$0.18 derived: net income ÷ weighted average shares · filed 2020-05-15 | -$0.25 derived: net income ÷ weighted average shares · filed 2020-05-15 |
| 2018-12-31 | -$0.09 derived: net income ÷ weighted average shares · filed 2020-03-30 | -$0.15 derived: net income ÷ weighted average shares · filed 2020-03-30 | -$0.22 derived: net income ÷ weighted average shares · filed 2020-03-30 | -$0.29 10-K · filed 2020-03-30 |
| 2018-09-30 | -$0.06 10-Q · filed 2019-11-14 | -$0.12 derived: net income ÷ weighted average shares · filed 2019-11-14 | -$0.19 10-Q · filed 2019-11-14 | $0.00 10-Q · filed 2018-11-08 |
| 2018-06-30 | -$0.06 10-Q · filed 2019-08-14 | -$0.13 10-Q · filed 2019-08-14 | -$0.19 derived: net income ÷ weighted average shares · filed 2019-08-14 | |
| 2018-03-31 | -$0.07 10-Q · filed 2019-05-15 | -$0.13 derived: net income ÷ weighted average shares · filed 2019-05-15 | ||
| 2017-12-31 | -$0.06 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |